Abbreviation	Explanation
ADAM-10	A disintegrin and metalloproteinase domain-containing protein 10
ADR	Adverse drug reactions
Akt	Protein kinase B
AP	Apigenin
BA	Baicalin
Bad	Bcl-2 antagonist of cell death
Bax	Bcl-2-associated X protein
BBR	Berberine; BC: breast cancer
Bcl-2	B-cell lymphoma 2
CDK	Cyclin-dependent kinase
Chk	Checkpoint kinase
CUR	Curcumin
DATS	Diallyl trisulfide
EGCG	Epigallocatechin-3-gallate
EGF(R)	Epidermal growth factor (receptor)
ER	Estrogen receptor
ERK	Extracellular signal-regulated kinase
5-FU	5-Fluorouracil
HCT	Hematocrit
IKK	IκB kinase
IL-1β	Interleukin 1 beta
IDS	Increase in drug sensitivity
JNK	C-Jun N-terminal kinase
Lin A	Lineariifolianoid A
MAML	Mastermind-like protein
MDM2	Mouse double minute 2 homolog
MEK	Mitogen-activated protein kinase kinase
MCF-7	Michigan Cancer Foundation 7
MDR1	Multidrug resistance 1
MG	Methylglyoxal
MMP	Matrix metalloprotein
mTOR	Mammalian target of rapamycin
mTORC-2	mTOR Complex 2
MRP1	Multidrug resistance protein 1
NFAT1	Nuclear factor of activated T cells 1
NF-κB	Nuclear factor kappa B
NICD	Notch receptor intracellular domain
p53	Inducible gene 3
PARP	Poly (ADP-ribose) polymerase
PDK1/2	3-phosphoinositide dependent kinase-1/2
PI3K	Phosphatidylinositol 3-kinase
PIP-3	Phosphatidylinositol (3,4,5)-trisphosphate
PPD	Protopanaxadiol
PTEN	Phosphatase and tensin homolog
RBP-Jκ	Recombinant signal binding protein for Immunoglobulin kappa J region
RSVL	Resveratrol
SAL	Salinomycin
TNBC	Triple-negative breast cancer
VEGF	Vascular endothelial growth factor
VOA	Voacamine
VS	Verminoside
WG	Wogonin